Topic: Complement and neutrophil cell activation in patients with coronary artery disease.
Recent publications
Saeed M, Tapia G, Ariansen I, Stene LC, Seljeflot I, Tell GS, Skrivarhaug T, Joner G(2021) Serum Galectin-3 and Subsequent Risk of Coronary Heart Disease in Subjects With Childhood-Onset Type 1 Diabetes: A Cohort Study Diabetes Care(in press) DOI 10.2337/dc20-1712, PubMed 33408220
Opstad TB, Berg TJ, Holte KB, Arnesen H, Solheim S, Seljeflot I(2020) Reduced leukocyte telomere lengths and sirtuin 1 gene expression in long-term survivors of type 1 diabetes: A Dialong substudy J Diabetes Investig DOI 10.1111/jdi.13470, PubMed 33249778
Tveit SH, Cwikiel J, Myhre PL, Omland T, Berge E, Seljeflot I, Flaa A(2020) Differential associations of cardiac troponin T and cardiac troponin I with coronary artery pathology and dynamics in response to short-duration exercise Clin Biochem(in press) DOI 10.1016/j.clinbiochem.2020.11.005, PubMed 33245871